📄 medicine

Association of Gestational Diabetes Mellitus With Growth Outcomes in Preschool- and School-Aged Offspring: A Follow-up Study

This retrospective cohort study of 575 mother–child pairs reveals that maternal gestational diabetes mellitus is independently associated with higher birth weight but significantly lower height-for-age Z scores in offspring during preschool and school age, suggesting a long-term impact on linear growth.

Original authors: kuncao bao, xiaowei lian, zimo wang, Kaifan Wang, Zhaoshan Jia, yilin wang, feng Wang, huifeng zhang

Published 2026-07-31

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: kuncao bao, xiaowei lian, zimo wang, Kaifan Wang, Zhaoshan Jia, yilin wang, feng Wang, huifeng zhang

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine your body as a high-tech construction site where a tiny, growing city is being built. The blueprint for this city comes from your DNA, but the actual building materials—bricks, mortar, and steel—are delivered by your mom while you are still inside her. Usually, this delivery system works perfectly, handing over just the right amount of sugar and nutrients to help the baby grow strong and tall. But sometimes, the delivery truck gets a little overloaded with sugar. This happens when a pregnant mom develops a condition called Gestational Diabetes Mellitus (GDM). Think of GDM as a temporary glitch where the mom's body struggles to manage sugar levels during pregnancy. While we know this glitch can make babies born a bit heavier (like a construction site that suddenly gets a massive shipment of extra bricks), scientists have been scratching their heads about what happens to the building once the construction crew leaves the site. Does the baby stay heavy, or does the extra sugar mess with how tall they grow later in life? This is the mystery researchers wanted to solve: does a sugar-glitch in the womb change the height of the child years later?

A team of researchers from hospitals in Hebei, China, decided to play detective to answer this question. They looked back at the records of 575 mother-and-child pairs, treating them like two different teams in a long-term experiment. One team, the "GDM Group," consisted of 219 children whose moms had gestational diabetes. The other team, the "Control Group," had 356 children whose moms had normal pregnancies. The researchers waited, on average, seven years (ranging from 4 to 10 years) to see how these kids turned out. They didn't just guess; they measured everything: how tall the kids were, how much they weighed, and even if they had any trouble seeing. To make sure they were comparing apples to apples, they used special "growth rulers" (called Z-scores) that adjust for a child's exact age and gender, so a 4-year-old isn't unfairly compared to a 10-year-old.

Here is what the detectives found, and it's a bit of a plot twist. First, the moms in the GDM group were generally older, heavier, and had more C-sections than the other moms. But the real story is in the kids. The children exposed to gestational diabetes were indeed born heavier, confirming the old idea that extra sugar makes for a bigger baby at birth. However, once they grew up into preschoolers and school-aged kids, the story changed. While their weight and body mass index (BMI) looked pretty much the same as the other kids, their height told a different tale. The GDM-exposed kids were, on average, shorter than their peers.

To be absolutely sure this wasn't just a coincidence caused by the moms being older or heavier, the researchers ran a complex math check (multivariable linear regression). Even after accounting for all those other factors, the link remained strong: being exposed to gestational diabetes in the womb was independently associated with being shorter. Specifically, the height score (HAZ) for the GDM group was significantly lower than the control group. The researchers also checked if this effect changed as the kids got older by splitting them into "little ones" (under 6) and "big kids" (over 6). The result? The height gap was there in both groups. It seems the effect of the sugar-glitch in the womb isn't just a baby thing; it lingers, suggesting that the blueprint for height might have been subtly altered before the child was even born.

Interestingly, the study also noticed that the GDM-exposed kids had a higher rate of visual impairment compared to the control group (17.8% vs. 7.9%), though the main focus of the paper was on growth. The researchers are careful to say this is a "suggestion" based on their data, not a final, unbreakable law of physics. They admit they couldn't track the kids' growth every single day, so they don't know exactly when the height difference started to show up, only that it was there when they checked in. They also couldn't get perfect details on how well the moms controlled their sugar during pregnancy, which is a missing piece of the puzzle.

So, what's the takeaway? If a mom has gestational diabetes, her baby might start life a bit heavier, but as they grow into childhood, they might face a challenge in reaching their full height potential. It's as if the extra sugar in the womb didn't just add bulk; it might have tweaked the construction schedule for the bones. The researchers suggest that doctors and parents should keep a close eye on the height and growth of children born to moms with GDM, not just their weight. It's a reminder that what happens in the womb can echo all the way through childhood, changing the trajectory of how a child grows up.

Technical Summary: Association of Gestational Diabetes Mellitus With Growth Outcomes in Preschool- and School-Aged Offspring

Problem Statement
Gestational Diabetes Mellitus (GDM) is a prevalent metabolic disorder affecting approximately 14% of pregnancies globally, characterized by inadequate pancreatic $\beta$ -cell compensation in response to pregnancy-induced insulin resistance. While extensive literature documents the immediate perinatal risks of GDM (e.g., macrosomia, neonatal hypoglycemia) and its long-term metabolic consequences for offspring (e.g., obesity, glucose intolerance), the specific impact of intrauterine hyperglycemia on skeletal development and linear growth remains insufficiently characterized. This study addresses the gap in understanding whether GDM exposure influences offspring height trajectories beyond the perinatal period and into childhood.

Methodology
This was a single-center retrospective cohort study conducted at the Second Hospital of Hebei Medical University, involving 575 mother–child pairs. The cohort consisted of 219 offspring exposed to maternal GDM and 356 controls with normal pregnancies.

Diagnosis: GDM was diagnosed using International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria via a 75-gram oral glucose tolerance test (OGTT) at 24–28 weeks gestation.
Data Collection: Maternal demographics, clinical characteristics, delivery modes, and neonatal birth weights were extracted from medical records.
Follow-up: The median follow-up duration was 7 years (range: 4–10 years). At follow-up, offspring anthropometrics (height, weight, BMI) and visual impairment status were assessed.
Analysis: Anthropometric data were converted to Z-scores (Height-for-Age [HAZ], Weight-for-Age [WAZ], BMI-for-Age [BAZ]) using WHO growth standards (AnthroPlus).
- Statistical Models: Multivariable linear regression was employed to evaluate the independent association between GDM and offspring HAZ, adjusting for maternal age, weight, height, delivery mode, offspring sex, and age at follow-up.
- Stratification: Age-stratified analyses were performed using 6 years as a cut-off to examine developmental stage variations.

Key Results

Maternal Characteristics: The GDM group was significantly older, had higher pre-pregnancy weight and BMI, and exhibited a higher rate of cesarean delivery compared to controls ( $P < 0.05$ ).
Birth and Follow-up Outcomes:
- Birth Weight: GDM-exposed offspring had significantly higher birth weights ( $3.46 \pm 0.51$ kg) compared to controls ( $3.34 \pm 0.34$ kg; $P = 0.002$ ).
- Linear Growth: Contrary to birth weight trends, GDM-exposed offspring demonstrated lower height during follow-up ( $1.22 \pm 0.13$ m vs. $1.25 \pm 0.14$ m; $P = 0.003$ ).
- Z-Scores: The median HAZ was significantly lower in the GDM group [0.65 (−0.08, 1.84)] compared to controls [1.09 (0.45, 1.87)] ( $P < 0.001$ ). No significant differences were found in WAZ or BAZ between groups.
- Visual Impairment: The prevalence of visual impairment was significantly higher in the GDM group (17.8% vs. 7.9%; $P < 0.001$ ).
Regression Analysis: After adjusting for confounders (maternal age, weight, height, delivery mode, offspring sex, and age), GDM exposure remained independently associated with lower offspring HAZ ( $B = -0.444$ , $P < 0.001$ ).
Age-Stratified Findings: The association between GDM and reduced height was observed in both early childhood (<6 years) and middle childhood ( $\ge$ 6 years), suggesting the effect persists across developmental stages. While early childhood GDM-exposed children showed numerically higher BMI, this trend did not reach statistical significance in the stratified analysis.

Significance and Claims
The study concludes that maternal GDM is associated with a dual growth phenotype: higher birth weight followed by reduced linear growth (lower HAZ) during childhood. The authors claim that this reduction in height is not merely a transient perinatal effect but represents a persistent alteration in growth trajectories that extends into school age.

The paper posits that intrauterine hyperglycemia may adversely affect skeletal development through mechanisms such as impaired placental vascular function, nutrient transport disruption, or persistent epigenetic/endocrine alterations (e.g., dysregulation of the growth hormone–insulin-like growth factor axis).

Limitations and Modesty
The authors explicitly acknowledge several limitations that temper the strength of their causal claims:

Retrospective Design: As a single-center retrospective study, residual confounding cannot be fully excluded, and causal relationships cannot be definitively established.
Data Gaps: Detailed maternal glycemic control data during pregnancy were largely obtained via telephone follow-up (subject to recall bias), and serial growth measurements were unavailable to characterize dynamic growth trajectories.
Interpretation: The authors urge caution in interpreting the non-significant trends in weight and BMI across age strata, noting that these require confirmation in longitudinal studies.

Conclusion
The study advocates for long-term growth monitoring of children born to mothers with GDM, specifically focusing on height and linear growth, in addition to standard metabolic surveillance. It suggests that managing GDM should include a perspective on long-term skeletal development outcomes.

Technical Summary: Association of Gestational Diabetes Mellitus With Growth Outcomes in Preschool- and School-Aged Offspring

More like this